Annual EBIT
-$126.94 M
-$38.08 M-42.86%
31 December 2023
Summary:
Athira Pharma annual earnings before interest & taxes is currently -$126.94 million, with the most recent change of -$38.08 million (-42.86%) on 31 December 2023. During the last 3 years, it has fallen by -$107.35 million (-548.03%). ATHA annual EBIT is now -2536.28% below its all-time high of -$4.82 million, reached on 31 December 2019.ATHA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$25.49 M
+$2.53 M+9.04%
30 September 2024
Summary:
Athira Pharma quarterly earnings before interest & taxes is currently -$25.49 million, with the most recent change of +$2.53 million (+9.04%) on 30 September 2024. Over the past year, it has increased by +$9.55 million (+27.25%). ATHA quarterly EBIT is now -2850.69% below its all-time high of -$864.00 thousand, reached on 31 December 2019.ATHA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$111.85 M
+$9.55 M+7.86%
30 September 2024
Summary:
Athira Pharma TTM earnings before interest & taxes is currently -$111.85 million, with the most recent change of +$9.55 million (+7.86%) on 30 September 2024. Over the past year, it has increased by +$6.14 million (+5.21%). ATHA TTM EBIT is now -7710.82% below its all-time high of -$1.43 million, reached on 30 September 2019.ATHA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATHA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.9% | +27.3% | +5.2% |
| 3 y3 years | -548.0% | -61.9% | -141.3% |
| 5 y5 years | -2394.8% | -1680.3% | -7710.8% |
ATHA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -548.0% | at low | -61.9% | +27.3% | -141.3% | +11.9% |
| 5 y | 5 years | -2536.3% | at low | -2850.7% | +27.3% | -7710.8% | +11.9% |
| alltime | all time | -2536.3% | at low | -2850.7% | +27.3% | -7710.8% | +11.9% |
Athira Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$25.49 M(-9.0%) | -$111.85 M(-7.9%) |
| June 2024 | - | -$28.03 M(+1.2%) | -$121.40 M(-2.9%) |
| Mar 2024 | - | -$27.69 M(-9.6%) | -$125.01 M(-1.5%) |
| Dec 2023 | -$126.94 M(+42.9%) | -$30.64 M(-12.6%) | -$126.94 M(+7.6%) |
| Sept 2023 | - | -$35.04 M(+10.8%) | -$118.00 M(+13.3%) |
| June 2023 | - | -$31.64 M(+6.8%) | -$104.13 M(+7.0%) |
| Mar 2023 | - | -$29.61 M(+36.5%) | -$97.31 M(+9.5%) |
| Dec 2022 | -$88.86 M(+61.0%) | -$21.70 M(+2.5%) | -$88.86 M(+6.3%) |
| Sept 2022 | - | -$21.17 M(-14.7%) | -$83.60 M(+6.9%) |
| June 2022 | - | -$24.83 M(+17.4%) | -$78.17 M(+16.0%) |
| Mar 2022 | - | -$21.15 M(+28.7%) | -$67.39 M(+22.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$55.19 M(+181.7%) | -$16.44 M(+4.4%) | -$55.10 M(+18.9%) |
| Sept 2021 | - | -$15.75 M(+12.1%) | -$46.36 M(+18.7%) |
| June 2021 | - | -$14.05 M(+58.4%) | -$39.07 M(+45.4%) |
| Mar 2021 | - | -$8.87 M(+15.1%) | -$26.87 M(+37.2%) |
| Dec 2020 | -$19.59 M(+306.8%) | -$7.70 M(-8.9%) | -$19.59 M(+53.6%) |
| Sept 2020 | - | -$8.46 M(+358.6%) | -$12.75 M(+122.6%) |
| June 2020 | - | -$1.84 M(+16.2%) | -$5.73 M(+47.5%) |
| Mar 2020 | - | -$1.59 M(+83.7%) | -$3.88 M(+69.1%) |
| Dec 2019 | -$4.82 M(-5.4%) | -$864.00 K(-39.7%) | -$2.30 M(+60.3%) |
| Sept 2019 | - | -$1.43 M | -$1.43 M |
| Dec 2018 | -$5.09 M | - | - |
FAQ
- What is Athira Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Athira Pharma?
- What is Athira Pharma annual EBIT year-on-year change?
- What is Athira Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Athira Pharma?
- What is Athira Pharma quarterly EBIT year-on-year change?
- What is Athira Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Athira Pharma?
- What is Athira Pharma TTM EBIT year-on-year change?
What is Athira Pharma annual earnings before interest & taxes?
The current annual EBIT of ATHA is -$126.94 M
What is the all time high annual EBIT for Athira Pharma?
Athira Pharma all-time high annual earnings before interest & taxes is -$4.82 M
What is Athira Pharma annual EBIT year-on-year change?
Over the past year, ATHA annual earnings before interest & taxes has changed by -$38.08 M (-42.86%)
What is Athira Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of ATHA is -$25.49 M
What is the all time high quarterly EBIT for Athira Pharma?
Athira Pharma all-time high quarterly earnings before interest & taxes is -$864.00 K
What is Athira Pharma quarterly EBIT year-on-year change?
Over the past year, ATHA quarterly earnings before interest & taxes has changed by +$9.55 M (+27.25%)
What is Athira Pharma TTM earnings before interest & taxes?
The current TTM EBIT of ATHA is -$111.85 M
What is the all time high TTM EBIT for Athira Pharma?
Athira Pharma all-time high TTM earnings before interest & taxes is -$1.43 M
What is Athira Pharma TTM EBIT year-on-year change?
Over the past year, ATHA TTM earnings before interest & taxes has changed by +$6.14 M (+5.21%)